|
Akzo Nobel India Limited (Akzoindia.NS) Évaluation DCF
IN | Basic Materials | Chemicals - Specialty | NSE
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Akzo Nobel India Limited (AKZOINDIA.NS) Bundle
Que vous soyez un investisseur ou un analyste, cette calculatrice (Akzoindians) DCF est votre ressource incontournable pour une évaluation précise. Chargé de données réelles d'Akzo Nobel India Limited, vous pouvez ajuster les prévisions et observer les effets en temps réel.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26,385.0 | 24,026.0 | 31,087.0 | 37,768.0 | 39,616.0 | 44,254.3 | 49,435.7 | 55,223.7 | 61,689.4 | 68,912.0 |
| Revenue Growth, % | 0 | -8.94 | 29.39 | 21.49 | 4.89 | 11.71 | 11.71 | 11.71 | 11.71 | 11.71 |
| EBITDA | 4,112.0 | 3,640.0 | 4,545.0 | 5,516.0 | 6,673.0 | 6,797.8 | 7,593.7 | 8,482.8 | 9,476.0 | 10,585.5 |
| EBITDA, % | 15.58 | 15.15 | 14.62 | 14.6 | 16.84 | 15.36 | 15.36 | 15.36 | 15.36 | 15.36 |
| Depreciation | 790.0 | 755.0 | 759.0 | 825.0 | 823.0 | 1,136.4 | 1,269.5 | 1,418.1 | 1,584.2 | 1,769.7 |
| Depreciation, % | 2.99 | 3.14 | 2.44 | 2.18 | 2.08 | 2.57 | 2.57 | 2.57 | 2.57 | 2.57 |
| EBIT | 3,322.0 | 2,885.0 | 3,786.0 | 4,691.0 | 5,850.0 | 5,661.4 | 6,324.2 | 7,064.7 | 7,891.8 | 8,815.8 |
| EBIT, % | 12.59 | 12.01 | 12.18 | 12.42 | 14.77 | 12.79 | 12.79 | 12.79 | 12.79 | 12.79 |
| Total Cash | 6,187.0 | 7,192.0 | 4,471.0 | 5,782.0 | 5,142.0 | 8,501.6 | 9,497.0 | 10,608.9 | 11,851.0 | 13,238.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 3,961.0 | 4,131.0 | 4,955.0 | 5,523.0 | 5,734.0 | 6,836.7 | 7,637.1 | 8,531.3 | 9,530.1 | 10,645.9 |
| Account Receivables, % | 15.01 | 17.19 | 15.94 | 14.62 | 14.47 | 15.45 | 15.45 | 15.45 | 15.45 | 15.45 |
| Inventories | 4,237.0 | 4,882.0 | 6,644.0 | 5,979.0 | 6,115.0 | 7,878.8 | 8,801.2 | 9,831.7 | 10,982.8 | 12,268.7 |
| Inventories, % | 16.06 | 20.32 | 21.37 | 15.83 | 15.44 | 17.8 | 17.8 | 17.8 | 17.8 | 17.8 |
| Accounts Payable | 6,752.0 | 7,972.0 | 8,451.0 | 8,634.0 | 9,975.0 | 11,859.8 | 13,248.3 | 14,799.5 | 16,532.2 | 18,467.9 |
| Accounts Payable, % | 25.59 | 33.18 | 27.18 | 22.86 | 25.18 | 26.8 | 26.8 | 26.8 | 26.8 | 26.8 |
| Capital Expenditure | -478.0 | -281.0 | -634.0 | -1,043.0 | -1,185.0 | -953.5 | -1,065.2 | -1,189.9 | -1,329.2 | -1,484.8 |
| Capital Expenditure, % | -1.81 | -1.17 | -2.04 | -2.76 | -2.99 | -2.15 | -2.15 | -2.15 | -2.15 | -2.15 |
| Tax Rate, % | 25.55 | 25.55 | 25.55 | 25.55 | 25.55 | 25.55 | 25.55 | 25.55 | 25.55 | 25.55 |
| EBITAT | 2,440.1 | 2,152.9 | 2,994.3 | 3,448.0 | 4,355.3 | 4,247.4 | 4,744.7 | 5,300.2 | 5,920.7 | 6,614.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 1,306.1 | 3,031.9 | 1,012.3 | 3,510.0 | 4,987.3 | 3,448.7 | 4,614.7 | 5,154.9 | 5,758.5 | 6,432.7 |
| WACC, % | 5.41 | 5.41 | 5.41 | 5.41 | 5.41 | 5.41 | 5.41 | 5.41 | 5.41 | 5.41 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 21,435.4 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 6,658 | |||||||||
| Terminal Value | 349,178 | |||||||||
| Present Terminal Value | 268,352 | |||||||||
| Enterprise Value | 289,787 | |||||||||
| Net Debt | -2,133 | |||||||||
| Equity Value | 291,920 | |||||||||
| Diluted Shares Outstanding, MM | 46 | |||||||||
| Equity Value Per Share | 6,410.15 |
Benefits You Will Enjoy
- Flexible Forecast Inputs: Effortlessly adjust key assumptions (growth %, margins, WACC) to explore various scenarios.
- Industry-Specific Data: Akzo Nobel India Limited’s financial data pre-loaded to give your analysis a head start.
- Instant DCF Calculations: The template automatically computes Net Present Value (NPV) and intrinsic value for your convenience.
- Professional and Tailored: A refined Excel model designed to meet your valuation requirements.
- Crafted for Analysts and Investors: Perfect for testing forecasts, assessing strategies, and optimizing your time.
Key Features
- Customizable Forecast Inputs: Adjust essential parameters such as revenue growth rate, EBITDA percentage, and capital investment.
- Instant DCF Valuation: Quickly calculates intrinsic value, NPV, and various financial metrics.
- High-Precision Accuracy: Leverages Akzo Nobel India's actual financial data for dependable valuation results.
- Easy Scenario Analysis: Effortlessly explore different assumptions and evaluate their impacts.
- Time-Efficient Solution: Avoid the hassle of creating intricate valuation models from the ground up.
How It Works
- Step 1: Download the ready-made Excel template containing data for Akzo Nobel India Limited (AKZOINDIANS).
- Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the recalculated results, including the intrinsic value of Akzo Nobel India Limited (AKZOINDIANS).
- Step 5: Make well-informed investment decisions or create reports based on the generated outputs.
Why Opt for the AKZOINDIANS Calculator?
- Precision: Utilizes authentic Akzo Nobel financial data for reliable results.
- Adaptability: Built for users to easily modify and experiment with different inputs.
- Efficiency: Eliminate the need to create a DCF model from the ground up.
- Expert-Level: Crafted with the accuracy and functionality expected by CFOs.
- Intuitive: Simple to navigate, making it accessible for users with limited financial modeling skills.
Who Can Benefit from This Product?
- Investors: Evaluate the valuation of Akzo Nobel India Limited (AKZOINDIANS) before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation processes and validate financial forecasts.
- Startup Founders: Understand the valuation methods applied to established companies like Akzo Nobel India Limited.
- Consultants: Provide detailed valuation reports to clients featuring Akzo Nobel India Limited (AKZOINDIANS).
- Students and Educators: Utilize real data from Akzo Nobel India Limited to practice and instruct on valuation techniques.
What the Template Includes
- Pre-Filled DCF Model: Akzo Nobel India Limited’s (AKZOINDIANS) financial data ready for immediate analysis.
- WACC Calculator: Comprehensive calculations for Weighted Average Cost of Capital.
- Financial Ratios: Assess Akzo Nobel India Limited’s profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions such as growth rates, margins, and capital expenditures to suit your needs.
- Financial Statements: Annual and quarterly reports available for in-depth analysis.
- Interactive Dashboard: Effortlessly visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.